| 2005 |
RC-74 (INTS9) is exclusively nuclear and forms a complex with RC-68 (INTS11) in HeLa and mouse cells. RC-74 lacks the histidine motif required for catalysis (unlike INTS11/RC-68 which retains it), and does not interact with CPSF-73 or CPSF-160, indicating that the RC-68/RC-74 complex is a separate entity from the canonical CPSF complex involved in a distinct pre-mRNA processing event. |
Co-immunoprecipitation, subcellular fractionation, sequence analysis, RNAi-mediated depletion with cell cycle phenotype readout |
Molecular and cellular biology |
Medium |
15684398
|
| 2005 |
RNAi-mediated depletion of RC-68 (INTS11), the catalytic partner of RC-74 (INTS9), arrests HeLa cells early in G1 phase while cells continue to grow, indicating a role for the RC-68/RC-74 complex in cell cycle progression through G1 into S phase. |
RNA interference with cell cycle analysis by flow cytometry |
Molecular and cellular biology |
Medium |
15684398
|
| 2012 |
INTS9 and INTS11 form a specific heterodimer mediated by a discrete C-terminal domain (CTD) of INTS9 and a corresponding region within the C-terminus of INTS11 adjacent to the predicted active site. This heterodimeric interaction is required for snRNA 3' end processing, as overexpression of the interaction domains alone causes dominant-negative snRNA misprocessing, and INTS11 lacking the INTS9-interaction domain cannot restore snRNA 3' end processing after RNAi depletion. |
Domain mapping, cell-based complementation assay, RNAi, dominant-negative overexpression |
Molecular and cellular biology |
Medium |
22252320
|
| 2017 |
Crystal structure of the INTS9-INTS11 CTD complex at 2.1-Å resolution reveals that the complex is composed of a continuous nine-stranded β-sheet with four strands from INTS9 and five from INTS11, with highly conserved residues forming an extensive interface. Structure-based mutagenesis confirmed that this interaction is crucial for snRNA 3' end processing. |
X-ray crystallography, yeast two-hybrid, co-immunoprecipitation, structure-based mutagenesis, snRNA 3' end processing functional assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
28396433
|
| 2018 |
INTS4 is a specific and conserved interaction partner of the INTS9/INTS11 heterodimer, forming a heterotrimeric cleavage module (INTS4/9/11). INTS4 does not interact with either INTS9 or INTS11 individually and requires both. INTS4 possesses N-terminal HEAT repeats and a β-sheet-rich C-terminal region both important for binding INTS9/INTS11. This trimeric complex is the most critical for UsnRNA biogenesis, Cajal body structural integrity, and histone locus body formation. |
Co-immunoprecipitation, domain mapping, UsnRNA 3' end processing assay, Cajal body/histone locus body imaging |
Nucleic acids research |
High |
29471365
|
| 2021 |
Cryo-EM structure of the INTS4/9/11 ternary complex at 3.5-Å resolution reveals spatial organization of the catalytic nuclease INTS11 bound to its catalytically impaired homolog INTS9 via several interdependent interfaces, with INTS4 playing a key role in stabilizing the nuclease domains. All three proteins form a composite electropositive groove suggesting a putative RNA-binding path within the complex. |
Cryo-electron microscopy at 3.5-Å resolution, biochemical characterization of subcomplexes |
Molecular cell |
High |
33548203
|
| 2021 |
WDR73 interacts with INTS9 and INTS11 components of the Integrator complex and is implicated in two Integrator-regulated cellular pathways: UsnRNA 3' end processing and mediating the transcriptional response to EGF stimulation. |
Co-immunoprecipitation, UsnRNA processing assay, transcriptional response assay |
Scientific reports |
Medium |
33686175
|
| 2022 |
Inositol hexakisphosphate (IP6) stably associates with the Integrator cleavage module (INTS4-INTS9-INTS11) at a highly electropositive pocket at the interface among all three subunits, 55 Å from the INTS11 active site. IP6 binding is conserved in human ICM and is required for Integrator function in snRNA 3' end processing and mRNA transcription attenuation; mutations in the IP6 binding site or disruption of IP6 biosynthesis significantly reduce Integrator function. |
Cryo-EM structure at 2.74 Å (Drosophila ICM), biochemical IP6-binding confirmation in human ICM, site-directed mutagenesis, snRNA processing assay, mRNA transcription attenuation assay |
Nature communications |
High |
36180473
|
| 2022 |
BRAT1 tightly interacts with INTS9/INTS11 subunits of the Integrator complex, and BRAT1 deletion disrupts Integrator functions including UsnRNA and snoRNA 3' end processing, replication-dependent histone pre-mRNA processing, and coding gene expression. |
Co-immunoprecipitation, BRAT1 knockout cells, RNA processing assays, transcriptomic analysis |
Nature communications |
Medium |
36028512
|
| 2022 |
SUMOylation of INTS11 (at Lys381, Lys462, Lys475) is regulated by SUMO isopeptidases USPL1 and SENP6 and modulates INTS11 subcellular localization and Integrator activity. An INTS11 SUMOylation-deficient mutant retains interaction with INTS4 and INTS9 but loses interactions with other Integrator subunits, suggesting SUMO conjugation on INTS11 regulates complex assembly. |
SUMO site mutagenesis, subcellular localization imaging, Co-immunoprecipitation, snRNA 3' end processing assay, USPL1/SENP6 overexpression |
Nucleic acids research |
Medium |
36454007
|
| 2024 |
BRAT1 and WDR73 are critical biogenesis factors for the Integrator cleavage module (INTS4-9-11). BRAT1 and WDR73 maintain INTS9-11 inactive during maturation by physically blocking the INTS11 endonuclease active site and prevent premature INTS4 association. BRAT1 facilitates nuclear import of the INTS9-11 heterodimer, and final BRAT1 release requires locking of the mature cleavage module conformation by IP6. |
Biochemical reconstitution, structural analysis, nuclear import assays, functional complementation assays |
Molecular cell |
High |
39032489
|
| 2024 |
Cryo-EM structure of the human INTS9-INTS11-BRAT1 complex reveals that the conserved C-terminus of BRAT1 is captured in the active site of INTS11, with a cysteine residue directly coordinating the metal ions, explaining how BRAT1 acts as a cytoplasmic chaperone that stabilizes INTS11 and is required for Integrator function in the nucleus. |
Cryo-EM structure determination, co-immunoprecipitation, neural organoid transcriptomic analysis, active-site mutagenesis inference from structure |
Molecular cell |
High |
39032490
|
| 2024 |
INTS11 and INTS9 form a distinct trimeric complex with BRAT1, and this complex is required for activation of REST-responsive neuronal genes during differentiation. BRAT1 recruits INTS11 to promoters of neuronal genes, and disease-causing mutations in BRAT1 (e.g., E522K) diminish association with INTS11/INTS9, preventing transcriptional activation and neuronal differentiation. |
Co-immunoprecipitation, ChIP, BRAT1 depletion/reconstitution with differentiation assay (NT2 cells), mouse ESC neuronal differentiation |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
38805275
|
| 2023 |
INTS9 and INTS11 subunits of the Integrator complex interact with BRAT1 to form a trimeric complex in HEK293T and NT2 cells. Disease-causing mutations in BRAT1 (E522K) diminish its association with the INTS11/INTS9 heterodimer, and BRAT1 depletion disrupts INTS11 recruitment to neuronal gene promoters and impairs neural differentiation. |
Co-immunoprecipitation, ChIP, RNAi-mediated depletion, differentiation assay |
bioRxivpreprint |
Medium |
37609215
|
| 2026 |
ZC3H18, a component linking nuclear exosome adaptors to transcription termination, directly recognizes the INTS9/INTS11 endonuclease module of the Integrator complex via a dedicated domain, as shown by in vitro biochemical approaches and cryo-EM. |
Cryo-EM, in vitro biochemical binding assays, in silico structure prediction-guided interface identification |
Nucleic acids research |
Medium |
41641703
|